Market Tracker

07/31 6:01pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

During the Trading Day
48.46 +0.10 / +0.21%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
48.46 0.00 / 0.00%
 
Volume: 16.7K

Today’s Trading

Previous close48.36
Today’s open48.65
Day’s range46.52 - 48.91
Volume889,166
Average volume (3 months)772,590
Market cap$3.5B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+6.83%
Earnings growth (next 5 years)+23.50%
Revenue growth (last year)+16.53%
P/E ratio76.4
Price/Sales3.75
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.47+0.56%
INSYINSYS Therapeutics I...+0.90+2.04%
CBPOChina Biologic Produ...+2.57+2.15%
WXWuXi PharmaTech (Cay...0.000.00%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.36
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts